Yatin Suneja

Stock Analyst at Guggenheim

(0)
# 4056
Out of 5,298 analysts
141
Total ratings
35.71%
Success rate
-9.23%
Average return
45 Stocks
Name Action Price Target Current % Upside Ratings Updated
PHAT Phathom Pharmaceutic...
Reiterates: Buy
n/a
n/a n/a 3 Apr 2, 2025
CABA Cabaletta Bio
Reiterates: Buy
23 23
1.2 1816.67% 3 Apr 1, 2025
ZURA Zura Bio
Reiterates: Buy
15 15
1.08 1288.89% 2 Mar 26, 2025
IFRX InflaRx
Maintains: Strong Buy
7 10
1.06 843.4% 5 Mar 26, 2025
LRMR Larimar Therapeutics
Reiterates: Buy
26 26
1.98 1213.13% 4 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
7 7
0.68 929.41% 1 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 8 Mar 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
84 84
16.96 395.28% 1 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
45 45
7.83 474.71% 3 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
775 1100
589.02 86.75% 9 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
165 163
102.86 58.47% 4 Feb 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 3 Jan 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
45 45
11.74 283.3% 3 Jan 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20 20
16.11 24.15% 6 Jan 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
90 36
19.25 87.01% 11 Dec 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Dec 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 2 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
50 65
13.96 365.62% 1 Oct 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
155 170
33.31 410.36% 2 Aug 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
1180 1300
610.24 113.03% 5 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
32
8.61 271.66% 1 Jul 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 May 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
50
5.85 754.7% 1 Apr 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
72 90
17.13 425.39% 4 Feb 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
110 125
107.92 15.83% 8 Feb 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
16 32
n/a n/a 3 Jan 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Dec 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 16
9.99 60.16% 2 Nov 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
70 77
38.09 102.15% 3 Nov 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Sep 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Jul 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
49
30.7 59.61% 2 Jun 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
52 55
4.98 1004.42% 2 May 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
270 350
130.65 167.89% 3 May 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
225 200
n/a n/a 3 Apr 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 5 Jan 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
98 117
n/a n/a 1 Dec 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
75
n/a n/a 1 Oct 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Oct 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
12.96 85.19% 1 May 31, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Apr 26, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
29 34
58.1 -41.48% 2 Jan 14, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
n/a
n/a n/a 1 Feb 22, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
60 80
n/a n/a 2 Jun 11, 2018